The Premier Event for Life Sciences Transactions
Structuring the Modern Biopharma Platform: Navigating Strategic Partnerships, M&A, and IP in Oncology & Beyond.
January 10-14, 2027
San Francisco, CA | Hybrid
The Institute for Life Sciences Transactions (ILST) convenes the world's leading Chief Business Officers, General Counsels, and Corporate Development executives. Our mission is to foster high-level dialogue on the mechanics of cross-border licensing, synthetic lethality partnerships, and IP defense strategies.
This year's plenary sessions focus on maximizing asset value in clinical-stage partnerships.
Navigating regulatory hurdles, milestone structures, and IP valuation in EU/US and Asia-Pac strategic alliances.
Deal structuring for advanced imaging, targeted PARP biology, and computational drug discovery platforms.
Protecting proprietary assays, small-molecule libraries, and navigating clinical trial data exclusivity.